TNGX 8-K 2026-01-08

Tango Therapeutics, Inc. (TNGX) 8-K dated 2026-01-08 — accession 0001193125-26-007086. This URL is the filing, not the TNGX hub.

Tango Therapeutics, Inc. (TNGX) is a biotechnology company listed on NASDAQ.

Tango Therapeutics, Inc. filed a 8-K on 2026-01-08. Accession 0001193125-26-007086.

Cached items: 2.02, 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.

Not investment advice. The TNGX SEC hub lists recent forms. The stock page is the research view.